Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Clinical and Experimental Rheumatology
|
May 1, 1996
Virus validation studies of immunoglobulin preparations
L Biesert
Vox Sanguinis
|
October 28, 1998
Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLAS
L Biesert, H Suhartono
European Journal of Biochemistry
|
February 2, 1987
Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes. Isolation and characterization of binding proteins
L Biesert, W Scheuer, W G Bessler
Research in Immunology
|
September 1, 1989
The membrane protein compositions of lipopolysaccharide- or lipoprotein-activated B lymphoblasts from C57BL LPS-responder and non-responder mice are qualitatively indistinguishable
B Kleine, L Biesert, W G Bessler
Immunitat Und Infektion
|
August 1, 1993
[Effect of antiviral agents]
H Rübsamen-Waigmann, A Pfützner, L Biesert
Journal of Chromatography. B, Biomedical Applications
|
July 21, 1995
Improved virus safety and purity of a chromatographically produced factor IX concentrate by nanofiltration
L Hoffer, H Schwinn, L Biesert, et al.
Biological Chemistry Hoppe-Seyler
|
October 1, 1986
Binding of a synthetic analogue of mitogenic bacterial lipoprotein to murine major histocompatibility complex (MHC) gene products
W V Scheuer, L Biesert, W G Bessler
European Journal of Biochemistry
|
March 1, 1982
DNA-dependent RNA polymerase of thermoacidophilic archaebacteria
D Prangishvilli, W Zillig, A Gierl, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
July 1, 1995
Virus validation experiments on the production process of OCTAVI SDPlus
L Biesert, S Lemon, H Suhartono, et al.
Journal of Medical Virology
|
April 1, 1996
Viral safety of a new highly purified factor VIII (OCTATE)
L Biesert, S Lemon, A Goudeau, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Clinical and Experimental Rheumatology
|
May 1, 1996
Virus validation studies of immunoglobulin preparations
L Biesert
Vox Sanguinis
|
October 28, 1998
Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLAS
L Biesert, H Suhartono
European Journal of Biochemistry
|
February 2, 1987
Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes. Isolation and characterization of binding proteins
L Biesert, W Scheuer, W G Bessler
Research in Immunology
|
September 1, 1989
The membrane protein compositions of lipopolysaccharide- or lipoprotein-activated B lymphoblasts from C57BL LPS-responder and non-responder mice are qualitatively indistinguishable
B Kleine, L Biesert, W G Bessler
Immunitat Und Infektion
|
August 1, 1993
[Effect of antiviral agents]
H Rübsamen-Waigmann, A Pfützner, L Biesert
Journal of Chromatography. B, Biomedical Applications
|
July 21, 1995
Improved virus safety and purity of a chromatographically produced factor IX concentrate by nanofiltration
L Hoffer, H Schwinn, L Biesert, et al.
Biological Chemistry Hoppe-Seyler
|
October 1, 1986
Binding of a synthetic analogue of mitogenic bacterial lipoprotein to murine major histocompatibility complex (MHC) gene products
W V Scheuer, L Biesert, W G Bessler
European Journal of Biochemistry
|
March 1, 1982
DNA-dependent RNA polymerase of thermoacidophilic archaebacteria
D Prangishvilli, W Zillig, A Gierl, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
July 1, 1995
Virus validation experiments on the production process of OCTAVI SDPlus
L Biesert, S Lemon, H Suhartono, et al.
Journal of Medical Virology
|
April 1, 1996
Viral safety of a new highly purified factor VIII (OCTATE)
L Biesert, S Lemon, A Goudeau, et al.
Page
of 3